News & Updates

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

Cognitive frailty predictors to aid dementia, adverse health outcome prevention

27 Jun 2023 by

Progression to cognitive frailty may be predicted by factors including vision, high-density lipoprotein cholesterol (HDL-C) levels, education levels, and participation in cognitively stimulating activities, according to a Singapore study.

Cognitive frailty predictors to aid dementia, adverse health outcome prevention

27 Jun 2023

Gliosis may explain depressive or cognitive symptoms after COVID

22 Jun 2023 by

Patients with persistent depressive or cognitive symptoms after an acute SARS-CoV-2 infection have elevated gliosis – a secondary event to brain injury – and inflammation as shown in a case-control study.

Gliosis may explain depressive or cognitive symptoms after COVID

22 Jun 2023

Early hysterectomy poses increased CVD risk

18 Jun 2023

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

Early hysterectomy poses increased CVD risk

18 Jun 2023

Eating disorders in kids: A global health emergency

14 Jun 2023 by

An elevated proportion of children and adolescents around the world, particularly girls or those with high BMI, experience disordered eating as shown in a meta-analysis of 32 studies from 16 countries.

Eating disorders in kids: A global health emergency

14 Jun 2023

AI brain MRI analysis tool aids Alzheimer’s disease prognostication

13 Jun 2023 by

A brain MRI–based artificial intelligence (AI) tool developed by researchers from the Chinese University of Hong Kong (CUHK) outperforms MRI markers such as hippocampal volume (HV) in predicting syndromal conversion of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) dementia, according to new data presented at Advances in Medicine (AIM) 2023.

AI brain MRI analysis tool aids Alzheimer’s disease prognostication

13 Jun 2023

Omega-3 fatty acids lower risk of dementia, cognitive decline

10 Jun 2023

Omega-3 polyunsaturated fatty acid intake provides neurological benefits by reducing the risk of Alzheimer’s disease (AD) or cognitive decline in older adults, reports a study.

Omega-3 fatty acids lower risk of dementia, cognitive decline

10 Jun 2023

Digital implant allows man with paralysis to walk again

09 Jun 2023 by

An electronic brain implant that acts as a “digital bridge” between the brain and the spinal cord has enabled a 40-year-old man with chronic tetraplegia to stand and walk on his own.

Digital implant allows man with paralysis to walk again

09 Jun 2023

Cocoa extract improves memory in older adults with flavanol-poor diet

07 Jun 2023 by

A large 3-year study of >3,500 older adults finds that flavanol-rich cocoa extract restores memory in participants with low-quality diet or low habitual flavanol consumption.

Cocoa extract improves memory in older adults with flavanol-poor diet

07 Jun 2023

Lower rates of relapse and discontinuation with ocrelizumab after natalizumab vs dimethyl fumarate and fingolimod in MS

07 Jun 2023 by

A retrospective observational cohort study finds that patients with relapsing-remitting multiple sclerosis (RRMS) who switched from natalizumab to ocrelizumab had lower annual relapse and discontinuation rates and longer time to first relapse than those who switched to dimethyl fumarate or fingolimod.

Lower rates of relapse and discontinuation with ocrelizumab after natalizumab vs dimethyl fumarate and fingolimod in MS

07 Jun 2023

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16-30 June 2023)

Original New Drug Application Approvals by US FDA (16-30 June 2023)

Cognitive frailty predictors to aid dementia, adverse health outcome prevention

Cognitive frailty predictors to aid dementia, adverse health outcome prevention

Gliosis may explain depressive or cognitive symptoms after COVID

Gliosis may explain depressive or cognitive symptoms after COVID

Early hysterectomy poses increased CVD risk

Early hysterectomy poses increased CVD risk

Eating disorders in kids: A global health emergency

Eating disorders in kids: A global health emergency

AI brain MRI analysis tool aids Alzheimer’s disease prognostication

AI brain MRI analysis tool aids Alzheimer’s disease prognostication

Omega-3 fatty acids lower risk of dementia, cognitive decline

Omega-3 fatty acids lower risk of dementia, cognitive decline

Digital implant allows man with paralysis to walk again

Digital implant allows man with paralysis to walk again

Cocoa extract improves memory in older adults with flavanol-poor diet

Cocoa extract improves memory in older adults with flavanol-poor diet

Lower rates of relapse and discontinuation with ocrelizumab after natalizumab vs dimethyl fumarate and fingolimod in MS

Lower rates of relapse and discontinuation with ocrelizumab after natalizumab vs dimethyl fumarate and fingolimod in MS